PMC:1472690 / 7466-8869 JSONTXT

{"project":"sentences","denotations":[{"id":"T51","span":{"begin":0,"end":130},"obj":"Sentence"},{"id":"T52","span":{"begin":131,"end":217},"obj":"Sentence"},{"id":"T53","span":{"begin":218,"end":284},"obj":"Sentence"},{"id":"T54","span":{"begin":285,"end":349},"obj":"Sentence"},{"id":"T55","span":{"begin":350,"end":415},"obj":"Sentence"},{"id":"T56","span":{"begin":416,"end":495},"obj":"Sentence"},{"id":"T57","span":{"begin":496,"end":571},"obj":"Sentence"},{"id":"T58","span":{"begin":572,"end":653},"obj":"Sentence"},{"id":"T59","span":{"begin":654,"end":747},"obj":"Sentence"},{"id":"T60","span":{"begin":748,"end":840},"obj":"Sentence"},{"id":"T61","span":{"begin":841,"end":931},"obj":"Sentence"},{"id":"T62","span":{"begin":932,"end":1017},"obj":"Sentence"},{"id":"T63","span":{"begin":1018,"end":1125},"obj":"Sentence"},{"id":"T64","span":{"begin":1126,"end":1234},"obj":"Sentence"},{"id":"T65","span":{"begin":1235,"end":1403},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Oligonucleotidesa Base sequences (5'- XXX -3') binding site/cytokine gene promoter (position of the cytokine gene from the TSS)b\nNFκBcS GAT CCT CAG AGG GGA CTT TCCc GAT G NFκB consensus sequence/TNFα promoter [27]\nNFκB1S GAT CCT GGG ACA GCC CAG NFκB1 sequence/TNFα promoter [27]\nNFκB2S GAT CCG GGG TAT CCT G NFκB2 sequence/TNFα promoter [27]\nNFκB3S GAT CCT GGG TTT CTC CG NFκB3 sequence/TNFα promoter [27]\nIL-8κBcS ATC GTG GAA TTT CCT CTG A NFκB consensus sequence/IL-8 promoter [28]\nNFATP2S GAT CTA AAA TTT CCA GTC CTT GA NFATP2 sequence/IFNγ promoter [29]\nNFIL-6S TGC AGA TTG CGC AAT CTG CA NFIL-6 consensus sequence/IL-6 promoter [13]\nNFκBcS GCG AGG AGG GTA TTT CCG CTT between -80 and -100 NFκB consensus/IL-1RA promoter [30]\nNFκB3S ACA ACA GCA AGG GTT TCT CTT TTT GGA AAT between -100 and -130 NFκB3/IL-1RA promoter\nNFκBcS AGT AGG GAG TTT GGT between -266 and -280 NFκB consensus sequence/IL-1RA promoter\nNFκB2/3S ACT CTG GGT ACC TGT between -288 and -302 NFκB2/3 sequence/IL-1RA promoter\nNFATP2/3S GGC GCA CAA AAC CTA AAA TAT TTA CTA TCT between -471 and -500 NFATP2/3 sequence/IL-1RA promoter\nNFIL-6S TTA CAA CAC TCC ATT GCG ACA CTT AGT GGG between -140 and -170 NFIL-6 sequence/IL-1RA promoter [31]\nOct-1 DNAS AAT TGC ATT GCC TGC AGG TCG ACT CTA GAG GAT CCA TGC AAA TGG ATC CCC GGG TAC CGA GCT C exclusion of unspecific bindings, unrelated DNA, (Amersham Pharmacia)"}